Bianchi G - Search Results

1

Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma.

Waldschmidt JM, Yee AJ, Vijaykumar T, Pinto RA, Frede J, Anand P, Bianchi G, Guo G, Potdar S, Seifer C, Nair MS, Kokkalis A, Kloeber JA, Shapiro S, Budano L, Mann M, Friedman R, Lipe B, Campagnaro E, O'Donnell EK, Zhang CZ, Laubach JP, Munshi NC, Richardson PG, Anderson KC, Raje NS, Knoechel B, Lohr JG. Waldschmidt JM, et al. Among authors: bianchi g. Leukemia. 2022 Apr;36(4):1078-1087. doi: 10.1038/s41375-021-01492-y. Epub 2022 Jan 13. Leukemia. 2022. PMID: 35027656 Free PMC article. Clinical Trial.

2

Targeting the UPS as therapy in multiple myeloma.

Chauhan D, Bianchi G, Anderson KC. Chauhan D, et al. Among authors: bianchi g. BMC Biochem. 2008 Oct 21;9 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-2091-9-S1-S1. BMC Biochem. 2008. PMID: 19007431 Free PMC article. Review.

3

Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.

Chauhan D, Singh AV, Brahmandam M, Carrasco R, Bandi M, Hideshima T, Bianchi G, Podar K, Tai YT, Mitsiades C, Raje N, Jaye DL, Kumar SK, Richardson P, Munshi N, Anderson KC. Chauhan D, et al. Among authors: bianchi g. Cancer Cell. 2009 Oct 6;16(4):309-23. doi: 10.1016/j.ccr.2009.08.019. Cancer Cell. 2009. PMID: 19800576 Free PMC article.

4

A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.

Görgün G, Calabrese E, Hideshima T, Ecsedy J, Perrone G, Mani M, Ikeda H, Bianchi G, Hu Y, Cirstea D, Santo L, Tai YT, Nahar S, Zheng M, Bandi M, Carrasco RD, Raje N, Munshi N, Richardson P, Anderson KC. Görgün G, et al. Among authors: bianchi g. Blood. 2010 Jun 24;115(25):5202-13. doi: 10.1182/blood-2009-12-259523. Epub 2010 Apr 9. Blood. 2010. PMID: 20382844 Free PMC article.

5

Molecular mechanisms of effectiveness of novel therapies in multiple myeloma.

Bianchi G, Ghobrial IM. Bianchi G, et al. Leuk Lymphoma. 2013 Feb;54(2):229-41. doi: 10.3109/10428194.2012.706287. Epub 2012 Sep 17. Leuk Lymphoma. 2013. PMID: 22897729 Review.

6

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.

Bianchi G, Kyle RA, Larson DR, Witzig TE, Kumar S, Dispenzieri A, Morice WG, Rajkumar SV. Bianchi G, et al. Leukemia. 2013 Mar;27(3):680-5. doi: 10.1038/leu.2012.237. Epub 2012 Aug 20. Leukemia. 2013. PMID: 22902364 Free PMC article.

7

The heavy chain diseases: clinical and pathologic features.

Bianchi G, Anderson KC, Harris NL, Sohani AR. Bianchi G, et al. Oncology (Williston Park). 2014 Jan;28(1):45-53. Oncology (Williston Park). 2014. PMID: 24683718 Free article. Review.

8

Best treatment strategies in high-risk multiple myeloma: navigating a gray area.

Bianchi G, Richardson PG, Anderson KC. Bianchi G, et al. J Clin Oncol. 2014 Jul 10;32(20):2125-32. doi: 10.1200/JCO.2014.55.7900. Epub 2014 Jun 2. J Clin Oncol. 2014. PMID: 24888801

9

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.

Bianchi G, Anderson KC. Bianchi G, et al. CA Cancer J Clin. 2014 Nov-Dec;64(6):422-44. doi: 10.3322/caac.21252. Epub 2014 Sep 29. CA Cancer J Clin. 2014. PMID: 25266555 Free article. Review.

10

Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.

Kikuchi S, Suzuki R, Ohguchi H, Yoshida Y, Lu D, Cottini F, Jakubikova J, Bianchi G, Harada T, Gorgun G, Tai YT, Richardson PG, Hideshima T, Anderson KC. Kikuchi S, et al. Among authors: bianchi g. Leukemia. 2015 Sep;29(9):1918-27. doi: 10.1038/leu.2015.83. Epub 2015 Mar 24. Leukemia. 2015. PMID: 25801913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,959 results

Search Page

Filters